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ABSTRACT The glutamate transporter GLT-1 from Rattus norvegicus was expressed at high level in baby hamster kidney
(BHK-21) cells by the Semliki Forest Virus expression system. We examined the expressed GLT-1 in the plasma membrane
and found that the transporter accumulates in detergent-insoluble lipid-protein assemblies. Freeze-fracture, immunogold
labeling, and electron microscopy revealed that GLT-1 forms ;200-nm protein-rich islands in the plasma membrane. Cho-
lesterol depletion in living cells resulted in a dispersion of the GLT-1 islands, indicating that they are the result of lipid-protein
rather than protein-protein interactions. Disruption of GLT-1 islands and dispersion of GLT-1 goes along with a reduction of the
glutamate transport activity. Our direct visualization of lipid-protein islands in the plasma membrane of tissue culture cells
suggests that the reported clustering of glutamate transporters and their cholesterol-dependent transport activity in cells is
likewise connected to their association with cholesterol-rich microdomains in the plasma membrane.
INTRODUCTION
Glutamate is the major excitatory neurotransmitter in mam-
malian brain. The concentration of glutamate in the synaptic
cleft is regulated by secondary glutamate transporters, which
maintain an extracellular concentration below neurotoxic
levels (1–5). The uptake process is electrogenic (6–8), in-
volving the cotransport of three sodium ions, one proton, and
one glutamate molecule, and the countertransport of one po-
tassium ion (9–11).
Of the ﬁve eukaryotic glutamate transporters identiﬁed
and cloned so far (GLT-1 (10), GLAST-1 (12), EAAC-1
(13), EAAT4 (14), EAAT5 (15)), GLT-1 is localized almost
exclusively to astrocytic plasma membranes, with a much
higher density of GLT-1 in membrane areas oriented to the
synaptic cleft than in other areas (16).
Several mechanisms have been proposed for the post-
translational regulation of glutamate transporters. For EAAC-1
it was shown that glutamate transport in African green
monkey kidney (COS) cells is rapidly increased after acti-
vation with PKC and that this is due to mobilization of
EAAC from intracellular stores (17,18). In contrast to EAAC-1,
no signiﬁcant intracellular concentrations of GLAST-1 and
GLT-1 have so far been detected in brain astrocytes, indi-
cating that these proteins are mostly found on the cell surface
(19). Other experiments have indicated that glutamate trans-
porters are regulated by a redox mechanism (20), by phos-
phorylation (21), or through the action of arachidonic acid
(22).
The lipid environment of glutamate transporters is impor-
tant for their activity. Experiments with GLT-1 reconstituted
into proteoliposomes indicated that cholesterol is required
for Na1-dependent [3H]-L-glutamate uptake (23). In addi-
tion, it has been shown that clustered GLT-1 is associated
with detergent-resistant membranes (DRM) isolated from
brain tissue (24). DRMs resemble the lipid-protein micro-
domains of the plasma membrane, also called lipid rafts that
are enriched in cholesterol and glycosphingolipids (25).
These cholesterol/sphingolipid-rich microdomains (CSRM)
are present in the plasma membrane of neurons as well as in
glia cells and are important in a variety of functions, espe-
cially signal transduction (25). A dynamic assembly of glu-
tamate transporters in CSRMs offers a suitable mechanism
for regulating the glutamate transport activity with an un-
changed copy number of transporters in the membrane.
We show here that glutamate transporter GLT-1 heterol-
ogously expressed in BHK cells enriches in DRMs and
associates with CSRMs in the plasma membrane. Immuno-
gold labeling and freeze-fracture electron microscopy re-
veals that the transporter clusters in 200-nm lipid-protein
microdomains in the plasma membrane. Cholesterol deple-
tion causes a disruption of the GLT-1 microdomains and a
concomitant reduction of glutamate transport activity.
MATERIALS AND METHODS
Strains and cell culture
Escherichia coli strain XL-1blue (Stratagene, La Jolla, CA) was used for
subcloning and propagation of recombinant plasmids. Semliki Forest virus
(SFV) was produced in the adherently growing baby hamster kidney cell line
BHK-21 [C-13] (ATTC, Manassas, VA). Another BHK-21 [C-13]-2P cell
line (ECACC, Salisbury, United Kingdom) was used routinely for the
expression of recombinant GLT-1 transporter genes. BHK-21 [C-13]-2P
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cells adapted to growth in suspension culture were grown in Glasgow-MEM
(modiﬁed Eagles medium) medium (Sigma-Aldrich, St. Louis, MO)
supplemented with 2 mM glutamine (Sigma-Aldrich), 5% tryptose
phosphate broth (Sigma-Aldrich), 10% fetal calf serum (PAA, Pasching,
Austria) and 1% penicillin/streptomycin-mix (1003) (Sigma-Aldrich). All
cells were maintained in a humidiﬁed atmosphere with 5% CO2 at 37C.
High-yield expression of GLT-1 in BHK-21 cells
Recombinant Semliki Forest virus particles containing the GLT-1 gene were
generated as described in detail elsewhere (26). Brieﬂy, linearized DNA was
puriﬁed with Microspin S-200 HR gel ﬁltration columns (Amersham,
Piscataway, NJ) before in vitro transcription. For RNA transcription 70 U
SP6 RNA polymerase (Fermentas, Burlington, Canada) and 1 mM
m79G(59)ppp(59)G Cap analog (New England Biolabs, Ipswich, MA) were
used. Electroporation of cells was repeated twice in a BioRad Gene Pulser II
(75 mF, 360 V, 10 V) with 0.2 cm Gene Pulser cuvettes (BioRad Labora-
tories, Hercules, CA). 48 h after virus production, the supernatant of the cells
was collected and passed through a 0.22-mm sterile ﬁlter. The virus sus-
pension was stored in aliquots at 80C. Virus particles were activated as
described (27). For infection of BHK-21 suspension cultures with activated
virus particles, the cells were grown to a density of;70–1003 104 cells/ml,
collected by centrifugation and resuspended in fresh medium (;70–100 3
105 cells/ml). Activated virus particles were mixed with the cell suspension
at the optimal virus titer and incubated at 37C in a CO2 incubator. 2 h after
infection the cell suspension was diluted with culture medium to a density of
70–100 3 104 cells/ml. The cells were cultured for 30 h.
Membrane preparation
Membranes were prepared as described previously (26). Brieﬂy, cells were
harvested by centrifugation and washed twice with phosphate buffered
saline (PBS). For homogenization cells were resuspended in 0.25 M sucrose,
25 mM HEPES, pH 7.4, 5 mM EGTA supplemented with 1 mM phenyl-
methanesulfonyl ﬂuoride (PMSF) and 2 ml/ml protease-inhibitor cocktail for
mammalian cells (PIM). The cell suspension was passed three times through
amicroﬂuidizer. Unbroken cells were removed by centrifugation at 30003 g
and 4C for 15 min. Membranes were pelleted at 100,000 3 g and 4C for
1 h and resuspended in 50 mM HEPES, pH 7.4, 200 mM NaCl, 2 mM
MgCl2, 2 mM EGTA, 20 mM b-mercaptoethanol including 0.1 mM PMSF
and 1 ml/ml PIM at a total protein concentration of 20 mg/ml (28). Aliquots
were snap-frozen in liquid nitrogen and stored at 80C.
Transport assays
Uptake of [3H]-L-aspartate (Amersham) was measured as described (29);
20 ml cell suspension was added to 360 ml 150 mM NaCl, 10 mM KPi, pH
7.4, and 100 nM [3H]-L-aspartate (29 Ci/mmol). Control experiments
without a Na1 gradient were performed using 150 mM choline chloride
instead of NaCl or with the nontransportable inhibitor (2S, 4R)-4-methyl
glutamate (SYM; Tocris, Bristol United Kingdom). Routinely, assays were
terminated after 10 min. Nitrocellulose ﬁlters with 0.45 mm pore size were
transferred to scintillation vials, mixed with scintillation ﬂuid (Rotiscint eco
plus, Roth, Karlsruhe, Germany). [3H]-L-aspartate or [3H]-L-glutamate was
determined with a scintillation counter TRI-CARB 1500 (Canberra-Packard,
Rissasanga, Canda).
Protein determination, SDS-PAGE, and
immunoblot analysis
Membrane protein concentration was determined by the method of
Bradford (28) or with a BCA assay kit (Pierce, Rockford, IL). For SDS-
PAGE, proteins were separated on a 10% polyacrylamide gel. After electro-
phoresis the proteins were either stained with Coomassie brilliant blue or
electroblotted onto polyvinylidene diﬂuoride membranes (Millipore, Bed-
ford, MA). As primary antibodies polyclonal rabbit anti-GLT-1 antibody
(1:1000, Alpha Diagnostic, San Antonio, TX) or mouse antiﬂotillin antibody
(1:250, Transduction Lab., Lexington, MA) was used. Bound antibodies
were detected with anti-rabbit IgG or anti-mouse IgG conjugated to alkaline
phosphatase. Biotinylated glutamate transporters were detected with alkaline
phosphatase streptavidin (Vector Laboratories, Burlingame, CA).
Labeling of cell-surface proteins
Cells were rinsed with ice-cold PBS containing 0.1 mM CaCl2 and 1 mM
MgCl2 and were incubated in the same solution supplemented with 1 mg/ml
N-hydroxysulfosuccinimido biotin (Pierce) for 20 min at 4C. After in-
cubation, cells were rinsed several times with PBS-Ca/Mg containing
100 mM glycine and incubated in this buffer for 30 min at 4C to quench the
unreacted biotin.
Freeze-fracture analysis
Cells were ﬁxed for 30 min in 2.5% glutaraldehyde in PBS at room
temperature and then transferred stepwise to 30% glycerol. A droplet of cell
suspension was placed between two copper sheets as sample holders and
frozen in ethane cooled with liquid nitrogen. Fracturing and shadowing were
carried out in a BAF T400 freeze-fracture machine (Balzers, Liechtenstein)
with a pressure of 2 3 107 mbar, keeping the specimen stage at  140C.
Pt/C shadowing was performed at an angle of 45 for Pt and 90 for pure
carbon. Unﬁxed BHK cells were used for freeze-fracture immunogold-
labeling. Replicas were labeled according to Fujimoto (30). Brieﬂy, the
replicas were thawed in 2.5% SDS in 10 mM Tris-HCl and 30 mM sucrose,
pH 8.3. After two changes of the SDS solution, replicas were stirred
overnight, washed in PBS, and incubated for 2 h with the speciﬁc primary
antibody (polyclonal rabbit anti-rat GLT-1 protein diluted 1:750 in PBS 1
0.1% BSA). To demonstrate binding sites of primary antibodies they were
reacted with a secondary gold-marker ligated antibody (goat antirabbit-Gold
(10 nm, Amersham). After a washing step, replicas were treated with 1%
glutaraldehyde/PBS, washed with water and placed on Formvar coated
copper grids for examination in the electron microscope.
Isolation and characterization of
detergent-resistant membranes
Detergent-resistant membranes (DRMs) were isolated as described (31) by
incubating 40 mg membranes with 1% (v/v) Triton X-100. Alkaline phos-
phatase was determined as described (32). Flotillin and GLT-1 were deter-
mined with SDS-PAGE followed by Western blot analysis with the
respective antibodies. The same amount of total protein was used for each
fraction. Lipids were extracted with chloroform-methanol (2:1 v/v). The
organic phase containing the lipids was recovered and the solvent was re-
moved by rotary evaporation. The extracted lipid was redissolved in
chloroform-methanol (2:1 v/v). Samples and standards were spotted on silica
gel TLC plates and developed in chloroform-methanol-acetic acid-water
(60:50:1:4 v/v). Spots were visualized with iodine vapor. Samples were
quantiﬁed densitometrically using the Kodak DSIC software package. Cho-
lesterol was determined by a cholesterol/peroxidase based assay (33), using
0.5% (w/v) methyl-b-cyclodextrin in combination with 15% (w/v) Brij 35
instead of sodium cholate.
Cholesterol depletion
Lovastatin (Sigma-Aldrich) was prepared as a 20 mM stock solution as
described (34). After infection with virus particles, BHK-21 suspension cells
were grown in medium containing 4 mM lovastatin and 0.25 mM
mevalonate for 30 h. The cells were pelleted and resuspended in medium
supplemented with 10 mM methyl-b-cyclodextrin. After treatment for
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30 min at 37C, the cells were washed several times in PBS and used for
aspartate/glutamate uptake measurements or freeze-fracture analysis.
RESULTS
Plasma membranes of BHK-21 cells overproducing GLT-1
were analyzed by freeze-fracture electron microscopy. This
revealed;200 nm islands of densely packed protein (Fig. 1A).
The average diameter of the protein particles in the island
was ;10 nm, in good agreement with the size of the GLT-1
complex (26). In control cells infected with empty SFV par-
ticles not containing the GLT-1 gene, these protein islands
were absent (Fig. 1 B). Immunogold-labeling of freeze-
fracture replicas with anti-GLT-1 primary antibody demon-
strated that the membrane protein in the densely packed
islands was indeed GLT-1 (Fig. 1 C). The microdomains
were not associated with invaginations in the membrane. We
also used different SFV titers to alter the GLT-1 expression
level (data not shown). The size of the protein patches did not
depend on the GLT-1 expression level. However, the total
number of observed protein islands decreased at reduced
protein expressions. We assumed that these protein islands
were associated with CSRMs of the membrane.
To verify this assumption, we used a routine procedure
(35) to extract detergent-insoluble fractions from BHK-21
plasma membranes containing GLT-1-with 1% Triton X-100
at 4C and ﬂotation on a sucrose density gradient. As a
control, we used membranes of cells that had been infected
with virus particles not containing the GLT-1 gene.
The DRM fractions were isolated by density gradient cen-
trifugation and identiﬁed in several ways (Fig. 2). Strong
light scattering at 620 nm served as a ﬁrst characteristic (36)
(Fig. 2 A). Most of the light-scattering material was found in
fraction 6, which also had the highest protein concentration
(Fig. 2 B). The characteristic detergent-resistant lipids, cho-
lesterol and sphingomyelin, were enriched in this fraction
(Fig. 2, C and E). GPI anchored proteins, such as alkaline
phosphatase and ﬂotillin are well-known marker proteins of
DRMs (37). To determine the accumulation of these proteins,
the enzyme activity of alkaline phosphatase was measured
(Fig. 2 D) and the distribution of ﬂotillin in the fractions of
interest was determined by Western blot analysis (Fig. 2 F).
Both alkaline phosphatase and ﬂotillin were highly enriched
in fraction 6. Taken together these results indicate clearly
that fraction 6 contained DRMs.
No signiﬁcant difference was observed between samples
with and without GLT-1. The DRM fraction was freeze-
fractured and analyzed by electronmicroscopy (Fig. 1D). The
main constituents were large multilayered membrane vesi-
cles, which apparently had formed after isolation by fusion
of rafts in the presence of detergent. The vesicles contained
high levels of protein and measured several micrometers in
diameter. The protein distribution in the vesicle membranes
was uneven. In most vesicles, membrane proteins were
FIGURE 1 GLT-1 assembles into protein-rich islands in
the plasma membrane, as shown by freeze-fracture elec-
tron microscopy. (A) Plasma membrane of BHK-21 cells
infected with SFV containing the GLT-1 gene. (Inset)
Boxed area at higher magniﬁcation, showing a typical
GLT-1 island. (B) Plasma membrane of control cells
infected with SFV not containing the GLT-1 gene. (C)
Immunogold labeling with anti-GLT-1 antibody of freeze-
fracture replicas from unﬁxed cells. (D) Isolated lipid rafts
containing GLT-1 (fraction 6) form single-walled vesicles
in which protein-rich clusters are laterally segregated
from large protein-free membrane areas. MV, sheared-off
microvilli.
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found exclusively in tightly clustered protein-lipid domains
continuous with large protein-free lipid areas. Western blot
analysis with anti-GLT-1 antibody (Fig. 2G) showed that the
glutamate transporter GLT-1 was highly enriched in the
DRM fraction (Fig. 2 G, lane 3), whereas no GLT-1 was
found in the control DRMs (Fig. 2 G, lane 6), as expected.
These experiments indicate that the expressed GLT-1 accu-
mulates in DRMs. However that does not prove that the
clustering of GLT-1 in protein islands we observed is due to
an interaction with lipids in CSRMs in the plasma mem-
brane, even if the lipid composition of these domains
resembles those of DRMs. To demonstrate the localization of
GLT-1 in CSRMs, we decided to disrupt the GLT-1 protein
islands in living cells.
CSRMs can be disrupted in vivo by reducing the amount
of cholesterol in the membranes, using a combination of two
different effects (38). First, the de novo synthesis of choles-
terol in the ER is inhibited by lovastatin in the presence of
small amounts of mevalonate to allow for the synthesis of
nonsterol products (39). Second, cholesterol is extracted from
the plasma membrane using methyl-cyclodextrin. Treatment
with lovastatin alone reduces the cholesterol levels only by
10% but it increases the effect of methyl-cyclodextrin. The
combination of the two methods makes it possible to reduce
FIGURE 2 Sucrose gradient fractions of DRMs. DRMs were extracted with 1% Triton X-100 from membranes of BHK-21 cells either expressing or not
expressing GLT-1. The raft fraction was isolated by ﬂotation on a sucrose gradient; 2 ml fractions were collected from the top. (A) Absorption at 620 nm; (B)
total protein content (mg/ml), measured with BCA; (C) cholesterol content (mg/ml); (D) alkaline phosphatase activity (nmol/mg protein/min). (E)
Sphingomyelin content of protein-containing fractions as determined by thin-layer chromatography. The distribution of the marker protein ﬂotillin (F) and
GLT-1 (G) was determined by SDS-PAGE andWestern blot. The same amount of total protein was applied to each lane. (E–G) Fractions 17, 10, and 6 of BHK
cells expressing GLT-1 (lanes 1–3); fractions 17, 10, and 6 of BHK cells not expressing GLT-1 (lanes 4–6).
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cholesterol in the plasma membrane of BHK cells by 60%
without affecting ER-to-Golgi transport (38).
BHKcells overproducingGLT-1were treatedwith lovastatin/
mevalonate for 30 h after infection. Cholesterol was extracted
with 10 mM methyl-b-cyclodextrin for 30 min immediately
before the cells were used for aspartate/glutamate uptake
measurements or freeze-fracture. Control cells were grown
without lovastatin/mevalonate and not treated with methyl-
b-cyclodextrin.
Cells grown in lovastatin/mevalonate showed a normal
growth rate compared to control cells (Fig. 3 A). Trypan blue
staining proved that the cells were viable after depletion of
cholesterol. Transport of aspartate/glutamate into intact BHK
cells was signiﬁcantly reduced by 30% upon cholesterol ex-
traction (Fig. 3 B). The observed change in transport activity
may result either from a reduction in the number of GLT-1
molecules in the plasma membrane or from a decrease in the
turnover rate of the transporters.
To discriminate between these two possibilities, we incu-
bated cells grown in lovastatin/mevalonate and control cells
in N-hydroxysulfo-succinimido biotin to biotinylate surface
proteins. Membranes were prepared and GLT-1 was puriﬁed
with a Ni-NTA column. The eluate was then analyzed by
SDS-PAGE and by Western blotting. There was no differ-
ence in the surface expression level of GLT-1 compared to
control cells (data not shown). Therefore the observed reduc-
tion of glutamate/aspartate transport after cholesterol deple-
tion was caused by a change in the turnover number and not
by a decrease in the copy number of transporter molecules on
the cell surface. Freeze-fracture analysis and electron micro-
scopy revealed that the characteristic GLT-1 transporter
islands had disappeared in the cells with reduced cholesterol
content (Fig. 3 C) whereas they were present in control cells.
The proteins were distributed equally in the plasma mem-
brane. Since activity tests of cells with GLT-1 patches indi-
cated a higher rate of aspartate/glutamate uptake than those
without patches, we can exclude the possibility that the pro-
tein islands were aggregates of inactive protein.
As an additional, unexpected effect, smooth, protein-free
lipid areas appeared in most of the membranes after cho-
lesterol depletion (Fig. 3 D). These smooth areas were appa-
rently due to a partial lateral segregation of lipid and protein
in the cell membrane.
In summary, a depletion of CSRMs in the membrane by
the reduction of cholesterol resulted in a disaggregation of
the GLT-1 transporter islands that went along with a reduc-
tion of aspartate/glutamate transport activity.
DISCUSSION
Our results show that heterologously expressed glutamate
transporter GLT-1 assembles into CSRMs in the plasma
membrane of BHK-21 cells. The diameter of the CSRMs as
determined from the size of the GLT-1 islands in freeze-
fracture replica was ;200 nm. Depending on the method
used, the postulated size of CSRMs, also called lipid rafts
FIGURE 3 Depletion of cholesterol
from the plasma membrane in living
cells (A). Growth curves of BHK cells
in the presence of (n) and without (:)
lovastatin/mevalonate. (B,C) BHK sus-
pension cells grown with or without
lovastatin/mevalonate were infected
with the same amount of SFV and
harvested after 30 h. After washing in
PBS the cells treated with lovastatin/
mevalonate were incubated with 10 mM
methyl-b-cyclodextrin in PBS for 30min
and the uptake of [3H]-L-aspartate in
the BHK cells was determined (B) or
the cells were freeze-fractured and
examined in the electron microscope
(C,D). The data in panel B represent the
mean of ﬁve separate experiments.
Plasma membranes of lovastatin/meva-
lonate-treated cells did not show the
characteristic GLT-1 islands but a more
or less uniform protein distribution (C).
However, most membranes of cells
treated in this way exhibited protein-
free lipid patches (arrows in D).
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ranges from a few molecules to ;700 nm. For instance,
homo and hetero FRET-based experiments revealed that
most GPI-anchored proteins in live cells are present mostly
as monomers and as nanoscale (,5 nm) cholesterol-sensitive
clusters (40). However, lipid rafts of 0.7 mm size were found
in native muscle cell membranes using single molecule
microscopy (41). The GLT-1 protein-lipid islands described
here are in the middle of this size range.
The GLT-1 islands were not associated with invaginations
in the membrane. Depletion of cholesterol from the plasma
membrane resulted in a disruption of the CSRMs and there-
fore of the GLT-1 islands. This coincided with a ;30%
reduction in glutamate transport activity.
The assembly of the protein in clusters might simply be a
side effect of the high-level expression of GLT-1. However,
the massive overexpression (3.5 3 106 transporters/cell or
;11,200 transporters/mm3, assuming a diameter of 10 mm
for a BHK-21 cell) (26) resembles the expression level of the
glutamate transporter GLT-1 in hippocampal tissue (12,000
transporters/mm3 hippocampus) (42). In natural tissue, in par-
ticular in neurons and astrocytes, the glutamate transporter is
also found in clusters that undergo rapid morphological
changes in both shape and size (16,43–45). It was suggested
that the morphogenesis of GLT-1 clusters is dependent on
the actin network and that their dynamic formation plays an
important role in regulating glutamate uptake (44). Indeed,
protein-lipid microdomains of the size we observe probably
require a scaffolding protein to link the GLT-1 transporters
together. In glia cells, the LIM-protein Ajuba has been pro-
posed to anchor the glutamate transporters to the cytoskel-
eton (46). Our results indicate however that GLT-1 clustering
is not only due to protein-protein interaction but also to lipid-
protein interaction.
Recently it was shown that GLT-1 in cortical astrocytes is
organized in DRMs (24,47), which were isolated either with-
out detergent (47) or by extraction with the detergent Brij-58
(24). In contrast to our results, GLT-1 was soluble in Triton
X-100. The fact that GLT-1 forms clusters in themembrane in
kidney cells, which do not naturally contain high levels of
glutamate transporters, proves that this is an inherent property
of the transporter and not speciﬁc to glia or nerve cells.
Extraction of DRMs is a method often used for analyzing
possible CSRM association of proteins. The detergent dis-
rupts lipid-protein interactions, so that most membrane pro-
teins are solubilized. Association of a protein in DRMs is
indicative of a strong interaction with tightly packed do-
mains in the cholesterol- and sphingolipid-rich Io phase (48).
The isolation of DRMs with different detergents as a charac-
terization of native CSRMs in cell membranes has been
debated recently. It was shown that the presence of proteins
or lipids in DRMs obtained with a particular detergent does
not necessarily indicate association with the same domains in
the native membrane (49). In addition, it was reported that
Triton X-100 used most frequently in these studies may
induce large-scale ordered domains in lipid vesicles that are
in turn resistant upon subsequent membrane solublization
(50). However, isolation of DRMs is still accepted as a valu-
able tool for the analysis of biological membranes including
cholesterol-sphingolipid rich microdomains (49) and proves
a high biochemical afﬁnity of proteins localized in DRMs for
the lipids that characterize these domains.
Our results show that the reduction of glutamate transport
is caused by the disruption of the CSRMs and a redistribu-
tion of the transporter in the membrane. The clustering must
bemediated by cholesterol-protein interaction, becausemem-
branes containing the same level of GLT-1 but only 40% of
the normal cholesterol level do not show the characteristic
protein microdomains as suggested in Fig. 4. We can there-
fore exclude direct interaction of the glutamate transporters
themselves as the cause of GLT-1 microdomain formation.
Cholesterol depletion is a common method for disrupting
CSRMs in vivo (38). Recently it was reported that depletion
of cell cholesterol can have global effects on cell and plasma
membrane architecture and function. In one case (51), cho-
lesterol depletion resulted in a reduced lateral mobility of
membrane proteins due to a reorganization of the actin cyto-
skeleton. By contrast, our observations and those of other
laboratories (52) indicate that cholesterol depletion leads to a
rapid and complete redistribution of CSRM proteins in the
membrane.
Our observations contrast with those of glutamate trans-
porters in rat primary brain cortical cultures that showed a
reduction of surface EAAT2 levels after depletion of cho-
lesterol. Butchbach et al. suggested that a depletion of mem-
brane cholesterol reduces the localization of the EAAT2 to
the cell surface by endocytosis of the human GLT-1 homolog
FIGURE 4 Proposed mechanism of activity regulation of GLT-1 by
cholesterol-induced association of GLT-1 into microdomains and their
dispersion upon cholesterol depletion. Clustering of GLT-1 is caused by
speciﬁc cholesterol binding to GLT-1, rather than by direct protein-protein
interaction. Low cholesterol levels prevent this interaction.
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EAAT2 (24). The observations that most GLAST-1 and
GLT-1 in brain astrocytes are found on the cell surface (19)
corroborate our results. Another argument against the endo-
cytosis hypothesis is that GLT-1 patches do not colocalize
with membrane invaginations. We conclude from this obser-
vation that GLT-1 does not associate with caveolar lipid
rafts. Caveolae are formed from lipid rafts by polymerization
of caveolins. They form ﬂask-shaped plasma membrane
invaginations and are involved in endocytosis (53,54). A
coimmuno-localization studywith antibodies directed against
caveolin-1 and GLT-1 in astroglial cells also showed that
GLT-1 is not located in caveolar lipid rafts (47).
Normally, it is difﬁcult to visualize CSRMs directly. First,
their relatively small size (up to a few 100 nm) makes it dif-
ﬁcult to examine them under the light microscope. Fluores-
cence-based approaches are relatively indirect. Second, the
density and concentration of the microdomain-associated
proteins is low. We present here the ﬁrst direct observation
by freeze-fracture electron microscopy of CSRMs connected
to the natural assembly of proteins in the membrane. In prin-
ciple, electron microscopy is a suitable technique for vis-
ualizing membrane domains in live cells but there are few
reports of this in the literature. Some signaling proteins
have been mapped by electron microscopy, although this
was limited to morphologically identiﬁable plasma mem-
brane structures such as caveolae (55,56) or osmiophilic
patches (57,58). A recent report combined immunogold elec-
tron microscopy with a statistical analysis of gold patterns to
visualize microdomain-resident proteins directly at high
resolution (52,59).
Normally, larger areas that can be examined by electron
microscopy are produced only after cross-linking of CSRM
proteins with antibodies (25). Evidently, the GLT-1 trans-
porter has a much stronger tendency to cluster than GPI-
anchored proteins or other characteristic CSRM proteins. The
reason for the strong interaction of GLT-1 in the membranes
must be the attractive force between the proteins and sur-
rounding lipids. A similar concentration of proteins in the
membraneswas observedwith glutamate receptors in neurons
of the neocortex and described as hot spots (60). It was also
postulated that AMPA receptors localize in lipid rafts (61). A
depletion of cholesterol/sphingolipids lead to instability of
surface AMPA receptors in neurons and gradual loss of
synapses.
Smooth, protein-free areas of ;200-nm size were ob-
served in the membrane after cholesterol depletion. Similar
large, particle-free smooth patches have been described be-
fore in unﬁxed mitochondrial and nuclear membranes
(62–64). It was found that temperatures below 10C before
freezing induced a lateral segregation of membrane proteins
and lipids into small protein-free lipid patches surrounded by
large membrane areas with a more or less even protein dis-
tribution. This does not occur if the membranes are ﬁxed at
room temperature or ;37C (64). Although we ﬁxed the
cells at room temperature before freezing, we observed lat-
eral lipid-protein segregation in cholesterol-depleted cells.
Control cells not subjected to cholesterol depletion did not
show this striking effect. Since otherwise the same condi-
tions were used in all experiments, this effect must be due to
methyl-cyclodextrin treatment and cholesterol depletion.
These physical changes in the membrane might reﬂect loss of
ﬂuidity at room temperature giving rise to lateral segregation
of lipid and protein, which occurs only at lower temperatures
in normal cells (65,66). A similar effect was observed in
giant unilamellar vesicles, in which bilayers of lipid mixtures
can separate laterally into coexisting liquid phases or do-
mains with distinct lipid compositions (67). At low choles-
terol concentration, solid, noncircular domains occur that
have a high melting point and that do not self-assemble (68).
These rigid lipid patches are probably due to strong lipid-
lipid interactions which would tend to expel interspersed
protein molecules. Physiological levels of cholesterol thus
apparently prevent the formation of protein-free lipid patches
in the plasma membrane at room temperature.
Functional signiﬁcance of GLT-I association
with CSRMs
In the bilayer of the membrane, many membrane proteins are
thought to be surrounded by a more or less tightly bound
shell of lipids (69). If a protein predominantly binds choles-
terol and glycosphingolipids, it would tend to form clusters
in the membrane, especially at high concentration. Therefore
the GLT-1 clusters do not necessarily have a functional role.
However, the density of glutamate transporters in astroglial
cells is much higher in regions of the plasma membrane that
are oriented to the synaptic cleft than in other areas (16).
Assuming the same uneven distribution of lipids in the
plasma membrane of glia cells that was found in epithelial
cells (70), an association of glutamate transporters with
CSRMs would enable their controlled trafﬁcking to choles-
terol and sphingomyelin-rich parts of the plasma membrane.
The dynamic assembly of GLT-1 into CSRMs and the
colocalization with cholesterol is likely to play a role in the
regulation of the transporter activity. Cholesterol is impor-
tant for the activity of the GLT-1 transporter as was shown
by proteoliposome reconstitution experiments (23) in which
cholesterol depletion reduced the GLT-1 activity. A choles-
terol-related regulation was also found for the expression and
activity of neuronal EAAC1 which are both regulated by
cholesterol (71). Experiments with other neuronal choles-
terol-regulated transporters such as the serotonin transporter
SERT-1 revealed that it is dynamically associated with
CSRMs. The afﬁnity of the transporter to serotonin was not
dependent on cholesterol, whereas the transport efﬁciency
depended on cholesterol bound to the transporter (72,73).
Likewise, the activity of the metabotropic glutamate receptor
in Drosophila melanogaster (74) and the rat GABA trans-
porter (23) has been shown to depend on cholesterol. This
receptor is also associated with CSRMs (75).
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Another reason for the dynamic association of glutamate
transporters with CSRMs may be their regulation by acti-
vators or inhibitors that colocalize in the same microdo-
mains. It was reported that GLT-1 is directly regulated by
arachidonic acid that is localized in CSRMs (22,76). Like-
wise, protein kinase C that has been reported to regulate
glutamate transporters via direct phosphorylation (21) is also
associated with CSRMs (25).
Taken together, our ﬁndings suggest that glutamate uptake
via glutamate transporters in glia cells is controlled by the
dynamic assembly of the transporters in CSRMs rather than
by a reduction of glutamate transporters on the cell surface
by endocytosis.
This work was supported by a PhD fellowship of ‘‘Studienstiftung des
deutschen Volkes’’.
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